"The high price of bad blood" (Top of the News, Sept. 27) stated that the National Hemophilia Foundation was demanding a settlement from Baxter International Inc. and three other suppliers to compensate hemophiliacs who contracted AIDS through clotting agents. The group is targeting four other suppliers besides Baxter.

Before it's here, it's on the Bloomberg Terminal. LEARN MORE